about
HIV treatment cascade in tuberculosis patientsHigh-levels of acquired drug resistance in adult patients failing first-line antiretroviral therapy in a rural HIV treatment programme in KwaZulu-Natal, South AfricaAn affordable HIV-1 drug resistance monitoring method for resource limited settingsTuberculosis pericarditis with cardiac tamponade: management in the resource-limited setting.Renal impairment in a rural African antiretroviral programme.Treatment of cryptococcal meningitis in KwaZulu-Natal, South Africa.The tuberculosis challenge in a rural South African HIV programme.Association of age with mortality and virological and immunological response to antiretroviral therapy in rural South African adults.Scale-up of a decentralized HIV treatment programme in rural KwaZulu-Natal, South Africa: does rapid expansion affect patient outcomes?Abdominal tuberculosis: sonographic diagnosis and treatment response in HIV-positive adults in rural South AfricaEvaluation of tuberculosis diagnostics: establishing an evidence base around the public health impact.Gender differences in survival among adult patients starting antiretroviral therapy in South Africa: a multicentre cohort study.Mortality among adults transferred and lost to follow-up from antiretroviral therapy programmes in South Africa: a multicenter cohort studyRetention in HIV care for individuals not yet eligible for antiretroviral therapy: rural KwaZulu-Natal, South Africa.Implementing antiretroviral resistance testing in a primary health care HIV treatment programme in rural KwaZulu-Natal, South Africa: early experiences, achievements and challenges.Cohort profile: Hlabisa HIV treatment and care programme.Management of hepatitis B in patients coinfected with the human immunodeficiency virus.International spread of MDR TB from Tugela Ferry, South Africa.Understanding Specific Contexts of Antiretroviral Therapy Adherence in Rural South Africa: A Thematic Analysis of Digital Stories from a Community with High HIV Prevalence.Time to eligibility for antiretroviral therapy in adults with CD4 cell count > 500 cells/μL in rural KwaZulu-Natal, South AfricaHuman resources needs for universal access to antiretroviral therapy in South Africa: a time and motion study.Impact of a novel molecular TB diagnostic system in patients at high risk of TB mortality in rural South Africa (Uchwepheshe): study protocol for a cluster randomised trial.Increasing HIV-1 Drug Resistance Between 2010 and 2012 in Adults Participating in Population-Based HIV Surveillance in Rural KwaZulu-Natal, South Africa.Collective patient behaviours derailing ART roll-out in KwaZulu-Natal: perspectives of health care providers.Disengagement from care in a decentralised primary health care antiretroviral treatment programme: cohort study in rural South Africa.Combined antiretroviral and anti-tuberculosis drug resistance following incarceration.Reduction in early mortality on antiretroviral therapy for adults in rural South Africa since change in CD4+ cell count eligibility criteria.Drug resistance in children at virological failure in a rural KwaZulu-Natal, South Africa, cohort.Are subtype differences important in HIV drug resistance?Implementing HIV-1 genotypic resistance testing in antiretroviral therapy programs in Africa: needs, opportunities, and challenges.Impact of Point-of-care Xpert MTB/RIF on Tuberculosis Treatment Initiation: A Cluster Randomised Trial.Poor long-term outcomes for cryptococcal meningitis in rural South Africa.Southern African Treatment Resistance Network (SATuRN) RegaDB HIV drug resistance and clinical management database: supporting patient management, surveillance and research in southern Africa.Short course for focused assessment with sonography for human immunodeficiency virus/tuberculosis: preliminary results in a rural setting in South Africa with high prevalence of human immunodeficiency virus and tuberculosisHIV drug resistance levels in adults failing first-line antiretroviral therapy in an urban and a rural setting in South Africa.Tuberculosis mortality and the male survival deficit in rural South Africa: An observational community cohort study.Fly caught in foreskin: an usual case of preputial myiasis.HIV and hepatitis B co-infection in Africa.Effect of the HIV epidemic on liver cancer in Africa.A malaria outbreak following a British military deployment to Sierra Leone.
P50
Q26782208-6C132588-BABC-40F9-9F1F-ED1A2BA90832Q28535483-BBBD9C8A-1473-4077-9132-62876EC77A41Q30486897-4EE21977-2C18-4818-A30A-EBB604F2D0B9Q30497443-70ADB3AC-F986-4B13-9266-F41F1CDD4412Q33498149-1D27E081-A65C-4590-BCC0-5C7AA2AE7D3DQ33523050-1B3A2477-C4F2-4DD0-B66D-C1A03E6377CAQ33530558-FF753AF7-5FD4-4624-85C3-4E9B6F742C2CQ33958103-94F51CB3-7BE2-402B-8431-DEAAE9F9169BQ34015581-04A7A97F-32EB-4FC2-B88F-2CC4470665E3Q34195620-9A6866DC-48E0-4B44-A51C-637D7D302AEEQ34224000-4ABE72B5-1DF5-4C9D-8FDB-8B1FF8327215Q34413586-67205FE3-EDCE-406C-86C9-82287BEC856DQ34551748-B0B1A155-116E-478B-A1B5-EE18C9D17741Q34776408-6F36D932-DC6F-46DE-9C3D-FCD6DF0D3BF0Q35114102-73356199-61AE-4E0D-8F5D-64A5B0E9BA16Q35367269-1D1033B0-92BC-4EAC-B457-8B2D735669F4Q35757754-25FDB56D-EC4F-4D61-B057-AAD8000E20C9Q35847213-49C5B97B-1598-4577-A189-58ECDE332139Q35940246-9D557CEF-F95F-4E27-92E6-921993E38AB7Q36380146-DEC89CC1-B62B-45AA-BF51-AEC72395AE07Q36487079-E4679112-BD84-432C-B235-3F696F9B6A11Q36940706-7C2A8B69-33A9-4D98-89AB-57092FA4A9AFQ37147719-1580F50E-638C-4618-962F-6EC10D8829A8Q37152891-78B4E303-F103-45C7-B55F-627460A80043Q37177440-379605ED-B8F0-40DF-9A37-5F7AF19B580BQ37333954-87D25DD3-A22B-434C-8F84-39EE00FD5F07Q37401923-676F53C3-C403-4A13-B364-02E1AE70F403Q37580891-44422A55-6288-4930-BA6F-1F4B0587FD9EQ37633109-16D39EF7-B896-4399-8C27-B93D1F1DBD71Q37634044-B1AFBDF2-6F3E-490B-9DE9-E95C5D81B3C1Q39172214-8B6E0575-0689-41CE-8784-ABAF616E2105Q39172243-AA0BC635-439E-4A94-96B1-93E08B82D25EQ39209322-B0EE0151-DBFF-4499-92C6-5B871D08DCDAQ39325496-BB377630-9F82-43DE-B850-4F60D38FC37FQ39410515-BA72E33D-13BB-4CA6-A20B-45C9745CB0CFQ41989069-5BE79650-23DC-4857-ADFB-6AE7BB9A8BD3Q42153130-3170F8CC-3FFF-40E4-A420-ECF54336CED2Q43827284-8FD5E857-ECEF-4AEB-AFC2-120002F341DEQ44355716-FAF23311-3F2B-41B3-89F9-32889EBB1ADFQ44726777-F260B78D-8429-44D0-864F-A6BD4B6130AB
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Richard Lessells
@ast
Richard Lessells
@en
Richard Lessells
@es
Richard Lessells
@nl
type
label
Richard Lessells
@ast
Richard Lessells
@en
Richard Lessells
@es
Richard Lessells
@nl
prefLabel
Richard Lessells
@ast
Richard Lessells
@en
Richard Lessells
@es
Richard Lessells
@nl
P108
P106
P108
P21
P31
P496
0000-0003-0926-710X